The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

President Trump held a phone call today with Vladimir Putin that he described as “lengthy and highly productive.” He characterized the conversation — the first confirmed talks between the two leaders ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

The results suggest the potential of semaglutide – the main ingredient in Ozempic and Novo’s higher-dose weight-loss drug ...

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol consumption.

Novo Nordisk A/S’s Ozempic helped reduce alcohol cravings in a small study, more evidence that the popular injections may ...